Back to search
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub).
Data up to Jan 2025
Published1989
Citations73
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...